![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?
Dopexamine is a newly developed sympathetic catecholamine which combines dopaminergic (DA-1) andβ 2-adrenergic agonist activity with only minorβ 1-adrenergic action...
-
Article
Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure
Beneficial effects of long-term treatment with dopamine analogues in patients with congestive heart failure may result from their vasodilating properties, in particular from renal artery vasodilation. Oral app...
-
Article
Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy
Phosphodiesterase inhibitors have vasodilating and positive inotropic properties, and these compounds may have energy saving effects due to vasodilation and energy consuming effects due to inotropism. In order...
-
Article
Preface
-
Article
Influence of isoproterenol on myocardial energetics. Experimental and clinical investigations
The influence of isoproterenol on myocardial performance and energetics was investigated in normal guinea pig myocardium and in patients with normal left ventricular function.
-
Article
Influence of the calcium-sensitizer UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy. Comparison with nitroprusside
UDCG-115 is a new cardiotonic agent which in vitro increases the sensitivity of the contractile proteins to calcium ions, inhibits the activity of phosphodiesterase, and prolongs the duration of the action pot...